Key Highlights
- Chemring Group PLC (LSE:CHG) remained in focus on 16 October 2026 after its Roke subsidiary signed a five-year agreement worth at least 170 million dollars with a major US defence contractor.
- The deal covers Roke's Nav-Sync Miniature Radar Altimeter, with an initial 16 million dollar production order for the first 12 months and deliveries starting in October 2026.
- Shares rose as much as 4% to 521 pence when the agreement was announced on 14 October.
- The group reported a record order book of about 1.4 billion pounds at 30 April 2026, with 91% of expected 2026 revenue delivered or already in the order book.
- Chemring's financial year ends on 31 October, putting full-year trading and Energetics expansion progress in view.
Why Chemring Is Firmly on the Radar
Chemring Group PLC (LSE:CHG), the FTSE 250 defence technology and energetics specialist, carried momentum into Friday 16 October 2026 after a significant export win for its Roke business. On 14 October the group announced that Roke had signed a five-year strategic agreement with a major US defence prime contractor, worth at least 170 million dollars, to supply its Nav-Sync Miniature Radar Altimeter. The shares climbed as much as 4% to 521 pence that day.
The agreement gives Roke a multi-year product revenue line, a stated growth priority, and the relationship is expected to run beyond the initial term to at least 2035. An initial 16 million dollar production order covers the first 12 months, with deliveries starting this month.
A filing on 6 October also showed Ignium II, LP raising its voting interest in Chemring to just over 14% from about 13%.
Inside the Roke Agreement
The altimeter is designed for high-speed platforms and uncrewed air vehicles, measuring altitude over land and sea in complex, low-altitude environments, and pairs a compact design with Roke's own algorithms and signal-processing hardware.
Chief executive Michael Ord said the deal advances Roke's strategy of growing revenue from defence products and systems, and demonstrates progress in its international business despite near-term headwinds in the UK defence market. That last point is important, because delays in UK government spending have weighed on the Sensors and Information division during the past year.
Business Background
Chemring Group PLC (LSE:CHG) operates through two main segments. Countermeasures and Energetics produces expendable decoys that protect aircraft and ships from missile threats, along with energetic materials, propellants and components used in munitions and space systems. Sensors and Information includes Roke, a UK-based science and engineering business working in cyber, electronic warfare, sensing and artificial intelligence, as well as chemical and biological detection and counter-explosive technologies.
The company has set an ambition to roughly double annual revenue to 1 billion pounds by 2030, supported by significant capacity investment in its Energetics operations in the United States, the UK and Norway.
Financial Position and Recent Trading
For the year to 31 October 2025, Chemring reported revenue of 497.5 million pounds, underlying operating profit of 73.5 million pounds and a record order book of 1.35 billion pounds, with a total dividend of 8.0 pence.
The interim results for the six months to 30 April 2026 showed revenue up about 7% to 237.3 million pounds, while underlying operating profit fell to 24.5 million pounds from 26.5 million pounds, reflecting weakness in Sensors and Information. Statutory profit was also hit by a 6.7 million pound impairment linked to retiring legacy countermeasures operations in Tennessee. The order book reached a new record of roughly 1.4 billion pounds, and the interim dividend rose 4% to 2.8 pence.
Net debt increased to 144.5 million pounds from 93.3 million pounds a year earlier, mainly because of about 44 million pounds of capital spending on Energetics capacity in the half. Leverage stood at 1.47 times underlying EBITDA. Management kept full-year expectations unchanged, noting that 91% of expected 2026 revenue was either delivered or in the order book. Progress on the expansion programme was described as encouraging, with the Chicago site complete and ramping, the Scottish facility in commissioning and Norway in its next phase.
Sector and Market Context
European and NATO defence budgets are rising, and management expects heightened demand to persist well into the next decade, with countermeasures and energetics benefiting from operational use, stockpile replenishment and new programmes. Strong sector sentiment makes contract news such as the Roke deal particularly influential.
Risks to Consider
UK procurement delays remain a near-term drag on Sensors and Information, and further slippage could weigh on margins. The Energetics expansion carries execution risk and has pushed up net debt, so delivering capacity on time and on budget is critical. Contract timing can create lumpy revenue, and currency movements matter given the large US business. Defence valuations already reflect strong demand assumptions, which leaves room for disappointment if orders or margins fall short.
What Investors Are Watching Next
With the financial year closing on 31 October, investors will watch for a year-end trading update and, later, full-year results, focusing on margin recovery in Sensors and Information, Energetics ramp-up, cash generation and the trajectory of net debt. Further international product wins at Roke, additional orders from NATO customers and updates on the 2030 revenue ambition will also shape the outlook for Chemring Group PLC (LSE:CHG).




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...